Can We Talk?: People who discuss their end-of-life wishes are less likely to die in a hospital or burden relatives with tough medical decisions. Here's how to get the conversation ...

Gordon, Debra

Neurology Now . 11(4):28-33, August/September 2015.

People who discuss their end-of-life wishes are less likely to die in a hospital or burden relatives with tough medical decisions. We can help get the conversation started.

Chemo Brain: Cognitive problems after cancer treatment are not imaginary.

Gordon, Debra

Neurology Now . 10(2):20-27, April/May 2014.

Cancer patients have talked for decades about cognitive changes after chemotherapy, but acceptance of “chemo brain” within the medical community is fairly recent. Here, cancer patients and neuro-oncologists discuss what people should know about chemotherapy-related changes in the brain.

Facing Pain: Diagnosing and treating the intense facial pain known as trigeminal neuralgia.

Gordon, Debra

Neurology Now . 8(2):26-28, April/May 2012.

Trigeminal neuralgia is a neurologic condition that causes intense facial pain. “When you ask patients to rate their pain on a scale of zero to 10, they typically give a number greater than 10,” says neurologist Gary Gronseth, M.D. Fortunately, a range of treatments are available.

A Flood of Emotions: Treating the uncontrollable crying and laughing of pseudobulbar affect.

Gordon, Debra

Neurology Now . 8(1):26-29, February-march 2012.

Many individuals with pseudobulbar affect—characterized by prolonged and unexplained episodes of laughing and crying—live in constant fear of their next outburst. Now, with one medication already approved by the FDA and other treatments in the works, patients may finally be able to regain control of their emotions and their lives.

Fragile X Syndrome: Research into Fragile X Syndrome, a common cause of inherited intellectual disability, is starting to generate treatments.

Gordon, Debra

Neurology Now . 7(5):37,45-49, October/November 2011.

Fragile X syndrome is the most common cause of inherited intellectual disability in boys, and the condition affects many girls as well. Now, a slew of new treatments are being tested in clinical trials. one day, some of them may help reverse the cognitive and developmental effects of this genetic disease.

An Ounce of Early Intervention: Can early treatment of neurologic disorders such as multiple sclerosis and Parkinson's disease slow disease progression?

Gordon, Debra

Neurology Now . 7(2):27-30, April/May 2011.

When it comes to neurologic disorders like multiple sclerosis (MS) and Parkinson's disease, early intervention can make a big difference. In the case of MS, early treatment may even alter the course of the disease, in addition to alleviating symptoms.

Early Intervention in Autism


Neurology Now . 5(5):23-26, September/October 2009.

Children with autism spectrum disorders can benefit from treatment at any age, but researchers are finding that early diagnosis and intervention may create the most dramatic improvements. Here, we explore some of the major forms of treatment and how they have improved the lives of three children.

The Six Million Dollar Arm


Neurology Now . 5(3):26-27,31, May/June 2009.

Just 23 years old and five months out of the Marines, Claudia Mitchell lost her left arm in a motorcycle accident. Jason Koger (left) lost both arms in an electrical accident. Today, they can move their prosthetic arms in complex ways—and in real time—just by thinking about it. These new “bionic” arms are the product of decades of work by Todd Kuiken, M.D., Ph.D., a physiatrist and biomechanical engineer.